pharmaceutical

Alibaba places shares into healthcare assets ($1.4 BILLION DEAL)

Alibaba places shares into healthcare assets ($1.4 BILLION DEAL)

Chinese e-commerce business Alibaba Group Holding Ltd (NYSE: BABA) sold some shares of pharmaceutical business to fund purchases of health-related assets through $1.4 billion deal.Alibaba Health Information Technology Ltd., a subsidiary of Alibaba, ..

Shire Shares Surge on Reports of Takeda Takeover Attempt

Shire Shares Surge on Reports of Takeda Takeover Attempt

Shire’s plc (NASDAQ: SHPG) shares surged by 17 percent on Wednesday following Takeda Pharmaceutical potential $40 billion bid midst acquisition and mergers in the pharmaceutical industry, according to CNBC.CNBC said Takeda is in its “pre..

Valeant Pharmaceuticals Posted Q4 Earnings

Valeant Pharmaceuticals Posted Q4 Earnings

On Wednesday, Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced its financial results for the fourth quarter of 2017. With revenue missing estimates and earnings beating estimates, shares of the company dropped 9% to $16.84 per share..

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Shares Up on Stronger than Expected Q4 Beat

AbbVie Inc. (NYSE: ABBV) reported its fourth quarter financial results for fiscal year 2017. The pharmaceutical company reported better than expected earnings sending shares 13.5 percent before market close on Friday.For the fourth quarter, AbbVie r..

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceuticals to Cut 25% of Jobs

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), based in Israel, is one of the world’s largest makers of generic drugs. The pharmaceutical giant has had a rough year, facing declining prices for generic drugs and the loss of a major branded d..

Teva May Cut 10,000 Jobs

Teva May Cut 10,000 Jobs

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has announced the cut of 10,000 jobs as the company aims to reduce $1.5 billion to $2 billion in costs over the next two years. Following this announcement, the drug maker’s U.S. shares increase..

Regeneron Pharma beats Q3 earnings

Regeneron Pharma beats Q3 earnings

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third quarter earnings for fiscal year 2017 and beat analysts’ estimates, sending shares up almost 7 percent shortly after open on Wednesday.For the third quarter, Regeneron reported r..